Testing effectiveness (Phase 2)Ended earlyNCT02100007What this trial is testingME-344 Given in Combination With Hycamtin® in Patients With Solid TumorsWho this might be right forSolid Tumors MEI Pharma, Inc. 46
Testing effectiveness (Phase 2)Study completedNCT00064311What this trial is testingRavuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell TransplantationWho this might be right forBreast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more National Institutes of Health Clinical Center (CC)
Not applicableStudy completedNCT00408681What this trial is testingLithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell TransplantWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+111 more Fred Hutchinson Cancer Center 20
Early research (Phase 1)Study completedNCT00083213What this trial is testingIntravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's LymphomaWho this might be right forCancer Regeneron Pharmaceuticals 25
Early research (Phase 1)Looking for participantsNCT07306559What this trial is testingTest How Well Different Doses of BI 3820768 Are Tolerated by People With Advanced Cancer (Solid Tumours)Who this might be right forAdvanced Relapsed or Refractory Germ Cell TumoursAdvanced Relapsed or Refractory Endometrial CancerAdvanced Relapsed or Refractory Ovarian Cancer Boehringer Ingelheim 187
Not applicableStudy completedNCT00049465What this trial is testingStandard Follow-up Compared With Extended Follow-up in Treating Patients Who Have Undergone Stem Cell Transplantation for CancerWho this might be right forCancer Fred Hutchinson Cancer Center
Not applicableStudy completedNCT00003538What this trial is testingPrevention of Graft-Versus-Host Disease in Patients Undergoing Bone Marrow TransplantationWho this might be right forCancer Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Early research (Phase 1)UnknownNCT02580747What this trial is testingTreatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART-mesoWho this might be right forMalignant MesotheliomaPancreatic CancerOvarian Tumor+3 more Chinese PLA General Hospital 20
Testing effectiveness (Phase 2)Study completedNCT00030706What this trial is testingIxabepilone in Treating Patients With Relapsed and/or Refractory Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal CancerWho this might be right forOvarian CancerPeritoneal Cavity Cancer Montefiore Medical Center
Very early researchUnknownNCT05180851What this trial is testingSafety and Efficacy of Recombinant Oncolytic Adenovirus L-IFN Injection in Relapsed/Refractory Solid Tumors Clinical StudyWho this might be right forHead and Neck CancerMelanomaBreast Cancer+4 more Shanghai Fengxian District Central Hospital 28
Early research (Phase 1)Ended earlyNCT05274451What this trial is testingInvestigate LYL797 in Adults With Solid TumorsWho this might be right forTriple Negative Breast CancerTNBC - Triple-Negative Breast CancerNon-small Cell Lung Cancer+20 more Lyell Immunopharma, Inc. 57
Not applicableStudy completedNCT00079222What this trial is testingVoriconazole Compared With Itraconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell TransplantationWho this might be right forCancer Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT02541370What this trial is testingTreatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART133Who this might be right forLiver CancerPancreatic CancerBrain Tumor+4 more Chinese PLA General Hospital 20
Early research (Phase 1)Study completedNCT00509691What this trial is testingVaccine Therapy in Treating Patients Who Have Undergone a Donor Stem Cell Transplant and Have Cytomegalovirus Infection That Has Not Responded to TherapyWho this might be right forCancer University of Louisville 20
Testing effectiveness (Phase 2)Ended earlyNCT00738699What this trial is testingAn Efficacy and Safety Study of MORAb-003 in Platinum-Resistant or Refractory Relapsed Ovarian CancerWho this might be right forOvarian Cancer Morphotek 415
Not applicableStudy completedNCT00082654What this trial is testingStudy of the Emotional Needs of Caregivers of Stem Cell Transplantation PatientsWho this might be right forBreast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more Fred Hutchinson Cancer Center
Early research (Phase 1)Study completedNCT00569283What this trial is testingDonor Natural Killer Cell Infusion in Preventing Relapse or Graft Failure in Patients Who Have Undergone Donor Bone Marrow TransplantWho this might be right forCancer Asan Medical Center 18
Testing effectiveness (Phase 2)Study completedNCT00003887What this trial is testingLymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell TransplantationWho this might be right forBreast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)UnknownNCT03916679What this trial is testingMESO-CAR T Cells Therapy for Relapsed and Refractory Epithelial Ovarian CancerWho this might be right forOvarian Cancer Second Affiliated Hospital, Zhejiang University, School of Medicine 20
Very early researchUnknownNCT05886075What this trial is testingA Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid TumorsWho this might be right forLung CancerBronchial CancerNon Small Cell Lung Cancer+9 more Shanghai Yunying Medical Technology 24